跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pyrazinamide-AFT pyrazinamide 500 mg tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
Pyrazinamide-AFT pyrazinamide 500 mg tablet bottle
Approved
STANDARD
Pyrazinamide-AFT pyrazinamide 500 mg tablet bottle
AFT Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
abc5ea2816058ce4
Company
AFT Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
abc5ea2816058ce4
Product Name
Pyrazinamide-AFT pyrazinamide 500 mg tablet bottle
Artg Id
413090
Artg Name
Pyrazinamide-AFT pyrazinamide 500 mg tablet bottle
Sponsor
AFT Pharmaceuticals Pty Ltd
Company Detail Path
/organization/aft-pharmaceuticals-au-pty-ltd
Artg Date
2025-05-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/60c06b5027ba7328beacb91f84b4e456.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/bb0d214f55f6aadfa2d420744ad3b19a.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
abc5ea2816058ce4
Type
Standard
Back to TGA Approvals